Fibroblast growth factor receptor 3 pseudogene 3 (FGFR3P3)

Fibroblast growth factor receptor 3 pseudogene 3 (FGFR3P3) is a genomic fragment classified as a pseudogene rather than a gene encoding a functional receptor. Pseudogenes are DNA sequences similar to known genes but are generally nonfunctional because of mutations or truncation, meaning FGFR3P3 does not produce a protein nor participate in canonical receptor activity, signaling, or cellular regulation. It differs fundamentally from fibroblast growth factor receptor 3 (FGFR3), which is an active receptor tyrosine kinase implicated in several developmental and oncological processes[1][3]. There is currently no evidence that FGFR3P3 is a therapeutic target, biomarker, or drug interaction site. Clarification: The name "fibroblast growth factor receptor 3 pseudogene 3" is scientifically accurate but is *not* a drug target, receptor, or functional gene product. The confusion usually arises from similarity to FGFR3, which *is* a pharmacogenomic and disease-relevant receptor[1][3]. For drug discovery, diagnostic, or functional annotation, use "Fibroblast growth factor receptor 3 (FGFR3)" instead of "FGFR3P3."[1][3] Summary of key points: - FGFR3P3 is a *pseudogene* and not a protein-coding drug target. - There is no receptor function, no known disease linkage, and no role in pharmacology. - Listings for drugs, mechanisms, and safety concerns are not applicable. - The target designation is *incorrect* for therapeutic or biomarker purposes.

Other names

FGFR3P3